Michael Milosevic spends much of his time researching Radiation therapy, Internal medicine, Surgery, Hypoxia and Cancer. His studies deal with areas such as Magnetic resonance imaging, Prostate cancer and Cervix as well as Radiation therapy. His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology.
The various areas that he examines in his Surgery study include Univariate analysis and Urology. His studies in Hypoxia integrate themes in fields like Pathology, Disease and Clinical significance. In general Cancer, his work in Metastasis is often linked to Clinical Practice linking many areas of study.
His primary areas of investigation include Radiation therapy, Internal medicine, Cervical cancer, Oncology and Cancer. His research integrates issues of Prostate cancer, Nuclear medicine and Chemotherapy in his study of Radiation therapy. Michael Milosevic has included themes like Dose fractionation and Magnetic resonance imaging in his Nuclear medicine study.
The study incorporates disciplines such as Gastroenterology and Pathology in addition to Internal medicine. Michael Milosevic has researched Cervical cancer in several fields, including External beam radiotherapy, Brachytherapy, Cisplatin, Lymph node and Dosimetry. A large part of his Cancer studies is devoted to Cervix.
Cervical cancer, Radiation therapy, Internal medicine, Brachytherapy and Cancer are his primary areas of study. His work deals with themes such as Hypoxia, Tumor hypoxia, Cisplatin, Radiology and Locally advanced, which intersect with Cervical cancer. Radiation therapy is a subfield of Surgery that Michael Milosevic studies.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology. His Brachytherapy research is multidisciplinary, incorporating perspectives in Magnetic resonance imaging, Mri guided, Medical physics and Nuclear medicine. His research in Cancer is mostly concerned with Cervix.
His scientific interests lie mostly in Radiation therapy, Internal medicine, Cervical cancer, Cancer and Oncology. His Radiation therapy study is concerned with Surgery in general. His Surgery research incorporates themes from Carcinoma in situ and Cystectomy.
His Cervical cancer research is multidisciplinary, incorporating elements of Cisplatin, Repeatability, Reproducibility, Stage and Cohort. The Cancer study combines topics in areas such as Hypoxia, Gastroenterology, Confidence interval, Physical therapy and Nanomedicine. His work focuses on many connections between Oncology and other disciplines, such as Chemoradiotherapy, that overlap with his field of interest in Primary tumor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Oxygenation predicts radiation response and survival in patients with cervix cancer
Anthony W Fyles;Anthony W Fyles;Michael Milosevic;Michael Milosevic;Raimond Wong;Raimond Wong;Mary-Claire Kavanagh.
Radiotherapy and Oncology (1998)
Expanding global access to radiotherapy
Rifat Atun;David A Jaffray;David A Jaffray;David A Jaffray;Michael B Barton;Freddie Bray.
(2015)
Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
A. Fyles;M. Milosevic;D. Hedley;M. Pintilie.
Journal of Clinical Oncology (2002)
Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States
Kathy Han;Michael Milosevic;Anthony Fyles;Melania Pintilie.
International Journal of Radiation Oncology Biology Physics (2013)
Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma
Normand J Laperriere;Phil M.K Leung;Stephen McKenzie;Michael Milosevic.
International Journal of Radiation Oncology Biology Physics (1997)
Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells
Antoaneta Belcheva;Thergiory Irrazabal;Susan J. Robertson;Catherine Streutker.
Cell (2014)
Interstitial Fluid Pressure Predicts Survival in Patients with Cervix Cancer Independent of Clinical Prognostic Factors and Tumor Oxygen Measurements
Michael Milosevic;Anthony Fyles;David Hedley;Melania Pintilie.
Cancer Research (2001)
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
Emilie Lalonde;Emilie Lalonde;Adrian S Ishkanian;Jenna Sykes;Michael Fraser;Michael Fraser.
Lancet Oncology (2014)
Diffusion-weighted MRI in cervical cancer
Patrick Z. McVeigh;Aejaz M. Syed;Michael Milosevic;Anthony Fyles.
European Radiology (2008)
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Vanessa E. Zannella;Alan Dal Pra;Alan Dal Pra;Hala Muaddi;Hala Muaddi;Trevor D. McKee.
Clinical Cancer Research (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
University of Manchester
Princess Margaret Cancer Centre
The University of Texas MD Anderson Cancer Center
University of Toronto
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre
Harvard University
McGill University
University of Catania
National Institute of Standards and Technology
University of Manchester
University of Tennessee at Knoxville
University Health Network
University of Queensland
University of Erlangen-Nuremberg
Polish Academy of Sciences
Statens Serum Institut
Cedars-Sinai Medical Center
Fujian Normal University
Florida State University
University of Michigan–Ann Arbor
University of California, San Diego